Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fusco

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Antioxidants (Basel, Switzerland)|May 27, 2023
Antioxidant and Anti-Inflammatory Properties of Walnut Constituents: Focus on Personalized Cancer Prevention and the MicrobiomeNuoxi Fan, Jennifer L Fusco, Daniel W Rosenberg
Brain & Development|November 10, 2001
Video/EEG aspects of early-infantile epileptic encephalopathy with suppression-bursts (Ohtahara syndrome)L Fusco, C Pachatz, M Di Capua, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Benign neonatal sleep myoclonus: clinical features and video-polygraphic recordingsM Di Capua, L Fusco, S Ricci, et al.
Nature Protocols|April 18, 2009
An efficient platform for screening expression and crystallization of glycoproteins produced in human cellsJeffrey E Lee, Marnie L Fusco, Erica Ollmann Saphire
Advances in Experimental Medicine and Biology|July 26, 2013
Paramyxovirus entryKatharine N Bossart, Deborah L Fusco, Christopher C Broder
Archives of Neurology|January 1, 1992
Double cortex. A neuronal migration anomaly as a possible cause of Lennox-Gastaut syndromeS Ricci, R Cusmai, G Fariello, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1992
Hemimegalencephaly and normal intellectual developmentL Fusco, S Ferracuti, G Fariello, et al.
Epilepsy Research. Supplement|January 1, 1992
Does an idiopathic west syndrome exist?F Vigevano, R Cusmai, D Claps, et al.
Neurology|January 10, 2001
EEG discharges on awakening: a marker of idiopathic generalized epilepsyF Fittipaldi, A Currà, L Fusco, et al.
Gynecologic Oncology|January 18, 2006
Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: a phase I Gynecologic Oncology Group studyPeter G Rose, Maurie Markman, Jeffrey G Bell, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Antioxidants (Basel, Switzerland)|May 27, 2023
Antioxidant and Anti-Inflammatory Properties of Walnut Constituents: Focus on Personalized Cancer Prevention and the MicrobiomeNuoxi Fan, Jennifer L Fusco, Daniel W Rosenberg
Brain & Development|November 10, 2001
Video/EEG aspects of early-infantile epileptic encephalopathy with suppression-bursts (Ohtahara syndrome)L Fusco, C Pachatz, M Di Capua, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Benign neonatal sleep myoclonus: clinical features and video-polygraphic recordingsM Di Capua, L Fusco, S Ricci, et al.
Nature Protocols|April 18, 2009
An efficient platform for screening expression and crystallization of glycoproteins produced in human cellsJeffrey E Lee, Marnie L Fusco, Erica Ollmann Saphire
Advances in Experimental Medicine and Biology|July 26, 2013
Paramyxovirus entryKatharine N Bossart, Deborah L Fusco, Christopher C Broder
Archives of Neurology|January 1, 1992
Double cortex. A neuronal migration anomaly as a possible cause of Lennox-Gastaut syndromeS Ricci, R Cusmai, G Fariello, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1992
Hemimegalencephaly and normal intellectual developmentL Fusco, S Ferracuti, G Fariello, et al.
Epilepsy Research. Supplement|January 1, 1992
Does an idiopathic west syndrome exist?F Vigevano, R Cusmai, D Claps, et al.
Neurology|January 10, 2001
EEG discharges on awakening: a marker of idiopathic generalized epilepsyF Fittipaldi, A Currà, L Fusco, et al.
Gynecologic Oncology|January 18, 2006
Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: a phase I Gynecologic Oncology Group studyPeter G Rose, Maurie Markman, Jeffrey G Bell, et al.
Pageof 9